Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.

Jackson, GH, Davies, FE, Pawlyn, C et al. (19 more authors) (2019) Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial. The Lancet Oncology, 20. pp. 57-73. ISSN 1470-2045

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the terms of a Creative Commons Attribution License (CC-BY 4.0).
Dates:
  • Published: January 2019
  • Accepted: 10 September 2018
  • Published (online): 14 December 2018
Institution: The University of Leeds
Academic Units: ?? Leeds.SU-LI22 ??
?? Leeds.DI-LI53 ??
Depositing User: Symplectic Publications
Date Deposited: 08 Jan 2019 14:44
Last Modified: 09 Jan 2019 09:11
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/s1470-2045(18)30687-9
Related URLs:

Share / Export

Statistics